drugset / Trial / NCT02607839

Regulation of Intestinal and Hepatic Lipoprotein Particle Production by Blood Glucose in Humans

NCT02607839

Phase 2 Completed 10 enrolled University Health Network, Toronto
RandomizedCrossoverSingle-blindBasic science

Summary

The purpose of study is to examine whether raised blood glucose enhances lipid particle production independent of effects on gastric emptying and pancreatic/ gastrointestinal hormone production.

Timeline

Start
2013-02
Primary completion
2015-04
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glucose Unknown 20 % Intravenous

Indications

No indication recorded.